title: Extensive genotyping of the BDNF and NTRK2 genes define protective haplotypes against obsessive-compulsive disorder.
abstract: BACKGROUND
  Family, twin and molecular studies provide increasing evidence for the importance of genetic factors in obsessive-compulsive disorder (OCD). Recent work suggests that brain-derived neurotrophic factor (BDNF) may be involved in OCD pathophysiology. We used a linkage disequilibrium (LD)-mapping approach to investigate the role that BDNF and its specific receptor neurotrophic tyrosine kinase receptor type 2 (NTRK2) may play in increasing susceptibility to OCD.
  
  
  METHODS
  Eight tag single nucleotide polymorphisms (tagSNPs) covering the BDNF gene region and 46 tagSNPs in the NTRK2 region were genotyped in 215 OCD patients and 342 control subjects. Single nucleotide polymorphism association and haplotype analysis were performed. The possible relationship between genetic factors and clinical characteristics including age of OCD onset, tic disorders, clinical dimensions, and family history of OCD were investigated.
  
  
  RESULTS
  Haplotype analysis revealed a significant association between OCD and a five-marker protective haplotype located toward the 5' of the BDNF gene (odds ratio [OR] = .80; 95% confidence interval [CI] = .69-.92; permutation p value = .006) containing the functional valine (Val)66-to-methionine (Met) variant. A significant association between a NTRK2 intronic SNP (rs2378672) and OCD was identified (p < .0001) in female patients under an additive model. A protective haplotype located in intron 19 of NTRK2 was also associated with OCD (OR = .76; 95% CI = .66-.87; permutation p value = .001).
  
  
  CONCLUSIONS
  These findings support a role for the BDNF/NTRK2 signaling pathway in genetic susceptibility to OCD.
authors: OCD Clinical and Research Unit, Psychiatry Department, Hospital Universitari de Bellvitge, Barcelona, Spain.
authors: Pino
authors: P
authors: Alonso
authors: Mónica
authors: M
authors: Gratacòs
authors: José M
authors: JM
authors: Menchón
authors: Jerónimo
authors: J
authors: Saiz-Ruiz
authors: Cinto
authors: C
authors: Segalàs
authors: Enrique
authors: E
authors: Baca-García
authors: Javier
authors: J
authors: Labad
authors: José
authors: J
authors: Fernández-Piqueras
authors: Eva
authors: E
authors: Real
authors: Concepción
authors: C
authors: Vaquero
authors: Mercedes
authors: M
authors: Pérez
authors: Helen
authors: H
authors: Dolengevich
authors: Juan R
authors: JR
authors: González
authors: Mónica
authors: M
authors: Bayés
authors: Rafael
authors: R
authors: de Cid
authors: Julio
authors: J
authors: Vallejo
authors: Xavier
authors: X
authors: Estivill
mesh_terms: D000293:Adolescent; D000328:Adult; D019208:Brain-Derived Neurotrophic Factor / Q000235:genetics*; D016022:Case-Control Studies; D005260:Female; D020022:Genetic Predisposition to Disease / Q000235:genetics* / Q000523:psychology; D005838:Genotype; D006239:Haplotypes / Q000235:genetics*; D006801:Humans; D015810:Linkage Disequilibrium; D008297:Male; D008875:Middle Aged; D009771:Obsessive-Compulsive Disorder / Q000175:diagnosis / Q000235:genetics* / Q000523:psychology; D010641:Phenotype; D020641:Polymorphism, Single Nucleotide / Q000235:genetics; D020813:Receptor, trkB / Q000235:genetics*
chemical_list: D019208:Brain-Derived Neurotrophic Factor; D020813:Receptor, trkB